Stockreport

Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals, Inc.  (RCKT) 
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rocketpharma.com
PDF Enrollment completed in September and dosing ongoing in the Phase 2 pivotal study of RP-A501 for Danon diseaseUpdated Phase 1 data from RP-A501 for Danon disease anticip [Read more]